Edition:
United States

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.15USD
23 Apr 2018
Change (% chg)

$-0.21 (-4.82%)
Prev Close
$4.36
Open
$4.35
Day's High
$4.35
Day's Low
$4.11
Volume
11,593
Avg. Vol
7,485
52-wk High
$8.56
52-wk Low
$3.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.625
Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
FY 2016 Dec '16 0.00 -0.098
Sep '16 0.00 -0.065
Jun '16 0.00 -0.092
Mar '16 0.00 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.65 32.31
P/E High - Last 5 Yrs. -- 40.53 46.12
P/E Low - Last 5 Yrs. -- 23.87 24.71
Beta -- 0.80 0.79
Price to Sales (TTM) -- 4.37 7.14
Price to Book (MRQ) 2.06 3.79 4.88
Price to Tangible Book (MRQ) 2.20 4.69 6.49
Price to Cash Flow (TTM) -- 21.39 24.37
% Owned Institutions 1.41 1.22 2.32

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.58
Dividend Yield - 5 Year Avg -- 0.76 0.78
Dividend 5 Year Growth Rate -- 2.85 4.08
Payout Ratio(TTM) -- 20.95 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 7.02 9.18
Sales (TTM) vs TTM 1 Yr. Ago -- 9.89 11.01
Sales - 5 Yr. Growth Rate -- 7.67 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -539.33 20.70 23.62
EPS (TTM) vs TTM 1 Yr. Ago -238.15 -- --
EPS - 5 Yr. Growth Rate -- 9.09 10.39
Capital Spending - 5 Yr. Growth Rate -- 9.75 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.51 2.52
Current Ratio (MRQ) 7.95 3.57 3.58
LT Debt to Equity (MRQ) 0.00 8.89 11.61
Total Debt to Equity (MRQ) 0.00 11.22 14.31
Interest Coverage (TTM) -2.97 36.66 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.94 54.20
Gross Margin - 5 Yr. Avg. -- 52.32 52.34
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.46 15.90
Operating Margin (TTM) -- 12.86 3.62
Operating Margin - 5 Yr. Avg. -- 14.17 11.17
Pre-Tax Margin (TTM) -- 13.10 4.27
Pre-Tax Margin - 5 Yr. Avg. -- 14.53 11.48
Net Profit Margin (TTM) -- 9.51 0.90
Net Profit Margin - 5 Yr. Avg. -- 10.85 7.81
Effective Tax Rate (TTM) -- 22.46 31.67
Effective Tax Rate - 5 Yr. Avg. -- 23.68 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 892,442,880 786,924,448
Net Income/Employee (TTM) -- 104,727,878 92,306,248
Receivable Turnover (TTM) -- 5.53 5.48
Inventory Turnover (TTM) -- 2.53 3.46
Asset Turnover (TTM) 0.00 0.90 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -109.61 10.76 10.35
Return on Assets - 5 Yr. Avg. -- 11.98 11.38
Return on Investment (TTM) -186.32 13.36 12.97
Return on Investment - 5 Yr. Avg. -- 15.50 14.74
Return on Equity (TTM) -220.23 15.09 14.84
Return on Equity - 5 Yr. Avg. -- 16.72 16.08
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -385.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.41%
# of Holders: 9
Total Shares Held: 145,274
3 Mo. Net Change: 1,710
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.